Community Conscience

Posted:
29
October 2007

The Facts

  • Breast cancer is the second most common cancer in the UK after non-melanoma skin cancer and over 44,100 new cases are diagnosed every year
  • Breast cancer claims the lives of 12,500 women each year in the UK. Men can also get breast cancer but it is rare (around 335 cases are diagnosed each year)
  • Of those women diagnosed with breast cancer today, two-thirds are likely to survive for at least 20 years
  • For more information please visit http://www.breastcancercare.org.uk/

Our Money

  • It is hoped that the money raised by Richmond Pharmacology will help to improve the survival rates of women with breast cancer for years to come
  • Richmond Pharmacology Ltd is pleased to have raised over �120 for breast cancer
Some of the Richmond Team
Some of the Richmond Team

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more